Clinical trial
Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation…
NCT00471991 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00471991 |
|---|---|
| Title | Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition |
| Official title | Monocenter, Open-label, Randomized Study to Determine the Ovulation Inhibitory Effect of the Combined Oral Contraceptive SH T04769G and SH D00659AF (0.03 mg Ethinylestradiol and 2.0 mg Dienogest), Applied for Two Treatment Cycles to 60 Healthy Female Volunteers |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Oral Contraceptive |
| Intervention type | Drug |
| Interventions | SH T04769G, Ethinyl estradiol / dienogest (SH D00659 AF) |
| Enrollment | 60 |
| Start date | Apr 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | May 10, 2007 |
| Last update posted | Jan 25, 2013 |
| Countries | Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: